Tamara McGrillen - RXi Pharmaceuticals Insider

RXi Pharmaceuticals Corporation -- USA Stock  

USD 3.43  0.13  3.94%

IR Contact Officer

We currently do not have informatin regarding Tamara McGrillen. This executive tanure with RXi Pharmaceuticals Corporation is not currenlty determined.
        
508-767-3861  http://www.rxipharma.com

Management Efficiency

The company has return on total asset (ROA) of (111.05) % which means that it has lost $111.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (395.58) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 6 records

EXECUTIVE Since

Carole HoDenali Therapeutics Inc
N/A
Sonja NelsonNantKwest Inc
2016
Jacob GeorgeVascular Biogenics Ltd
2000
Shayla ForsterVBI Vaccines Inc
2015
David AndersonVBI Vaccines Inc
2015
Ayelet HornVascular Biogenics Ltd
2016

Entity Summary

RXi Pharmaceuticals Corporation, a clinical-stage company, focuses on developing therapeutics for unmet medical needs. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. RXi Pharmaceuticals operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets exchange. It employs 15 people.RXi Pharmaceuticals Corporation (RXII) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 15 people. RXi Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Equity Valuation Now
   

Equity Valuation

Check real value of public entities based on technical and fundamental data
Hide  View All  NextLaunch Equity Valuation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add RXi Pharmaceuticals Corporation to your portfolio

Top Management

RXi Pharmaceuticals Leadership Team
Geert Cauwenbergh, CEO, Ph.D
Robert Bitterman, Director, MBA
Pamela Pavco, Executive, Ph.D
Keith Brownlie, Director
Jonathan Freeman, Director, MBA
Gerrit Dispersyn, Executive
Curtis Lockshin, Director, Ph.D
Paul Dorman, Director
Alexey Eliseev, Executive
Tamara McGrillen, Executive

Stock Performance

RXi Pharmaceuticals Performance Indicators